EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Eosinopenia in bronchiectasis: A novel biomarker for morbidity and mortality

Shimon Izhakian iD, Ravid Yehezkely, Assaf Frajman, Ori Mekiten, Ori Hadar, Avigail Rockland, Liel Malka, Lev Freidkin iD, Dror Rosengarten, Mordechai R Kramer

Chronic Respiratory Disease · 2025

DOI: 10.1177/14799731241296847 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Chronic Respiratory Disease, 2025. Verfasst von Shimon Izhakian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Institute, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel. Hauptthemen laut MEDLINE: Bronchiectasis, Eosinophils, Eosinophilia, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The paradigm of bronchiectasis is shifting away from its exclusive characterization as a neutrophilic condition. Patients with bronchiectasis and high eosinophil levels have been found to have a specific phenotype, but the clinical effect of eosinopenia remains unclear.

Method

A retrospective, single-center, observational study was conducted at a tertiary medical center. Adult patients under follow-up for bronchiectasis from January 2007 to August 2020 were categorized by blood eosinophil count (BEC) as follows: eosinopenia (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BronchiectasisEosinophilsEosinophiliaBiomarkersHumansFemaleMaleMiddle AgedRetrospective StudiesAgedLeukocyte CountDisease ProgressionHospitalizationLeukocyte Disorders

Stichwörter der Autor:innen

Eosinophilsbronchiectasisexacerbation

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Pulmonary Institute, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • The Adelson School of Medicine, Ariel University, Ariel, Israel.

ORCID-Profile: Shimon Izhakian, Lev Freidkin

Zitieren

APA

Izhakian, S., Yehezkely, R., Frajman, A., Mekiten, O., Hadar, O., Rockland, A., Malka, L., Freidkin, L., Rosengarten, D., & Kramer, M. R. (2025). Eosinopenia in bronchiectasis: A novel biomarker for morbidity and mortality. Chronic Respiratory Disease. https://doi.org/10.1177/14799731241296847

Vancouver

Izhakian S, Yehezkely R, Frajman A, Mekiten O, Hadar O, Rockland A, et al. Eosinopenia in bronchiectasis: A novel biomarker for morbidity and mortality. Chronic Respiratory Disease. 2025. doi:10.1177/14799731241296847

BibTeX
@article{Izhakian2025,
  author = {Izhakian, Shimon and Yehezkely, Ravid and Frajman, Assaf and Mekiten, Ori and Hadar, Ori and Rockland, Avigail and Malka, Liel and Freidkin, Lev and Rosengarten, Dror and Kramer, Mordechai R},
  title = {Eosinopenia in bronchiectasis: A novel biomarker for morbidity and mortality},
  journal = {Chronic Respiratory Disease},
  year = {2025},
  doi = {10.1177/14799731241296847}
}
Kostenlos starten →